| Literature DB >> 29212816 |
Annika Scior1, Alexander Buntru2, Kristin Arnsburg1, Anne Ast2, Manuel Iburg1, Katrin Juenemann1, Maria Lucia Pigazzini1,3, Barbara Mlody2, Dmytro Puchkov1, Josef Priller4, Erich E Wanker5, Alessandro Prigione2, Janine Kirstein6.
Abstract
Huntington's disease (HD) is a neurodegenerative disorder caused by an expanded CAG trinucleotide repeat in the huntingtin gene (HTT). Molecular chaperones have been implicated in suppressing or delaying the aggregation of mutant Htt. Using in vitro and in vivo assays, we have identified a trimeric chaperone complex (Hsc70, Hsp110, and J-protein) that completely suppresses fibrilization of HttExon1Q48 The composition of this chaperone complex is variable as recruitment of different chaperone family members forms distinct functional complexes. The trimeric chaperone complex is also able to resolubilize Htt fibrils. We confirmed the biological significance of these findings in HD patient-derived neural cells and on an organismal level in Caenorhabditis elegans Among the proteins in this chaperone complex, the J-protein is the concentration-limiting factor. The single overexpression of DNAJB1 in HEK293T cells is sufficient to profoundly reduce HttExon1Q97 aggregation and represents a target of future therapeutic avenues for HD.Entities:
Keywords: HttpolyQ; NPCs; disaggregation; molecular chaperones; suppression
Mesh:
Substances:
Year: 2017 PMID: 29212816 PMCID: PMC5770855 DOI: 10.15252/embj.201797212
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598